Gene Therapy - Table of Contents alert Volume 24 Issue 3

If you are unable to see the message below, click here to view.

Advertisement Looking for cGMP AAV and Lentivirus Production?  Proven cGMP facility, team and quality system for CAR-T and gene therapy  Read more for cGMP floor plan and QC tests. TABLE OF CONTENTS Volume 24, Issue 3 (March 2017) In this issue Editorials Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement Gene Therapy for Rare Disorders 2017 Gene Therapy for Rare Disorders 2017 is the only conference dedicated to overcoming clinical, manufacturing, regulatory and commercialization challenges in this space. Hear in-depth case studies from Pfizer, UniQure, GSK, Bluebird, FDA and EMA on realizing the commercial potential of gene therapies.  View the event guide for full details    Advertisement NYU Nature Conference on Neurogenetics  August 9-11, 2017| New York, NY Presented by: New York University (NYU) | Nature Genetics | Nature Neuroscience  Register now! Editorials Top Prospects for RNA delivery with nanotechnologies S L Hart Gene Ther 2017 24: 121; 10.1038/gt.2017.15 Full Text Double TALEN-edited T-cells kick B-ALL into touch P T Harrison Gene Ther 2017 24: 122; 10.1038/gt.2017.17 Full Text Reviews Top Graphene materials as 2D non-viral gene transfer vector platforms M Vincent, I de Lázaro and K Kostarelos Gene Ther 2017 24: 123-132; advance online publication, November 22, 2016; 10.1038/gt.2016.79 Abstract | Full Text Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems S Guan and J Rosenecker Gene Ther 2017 24: 133-143; advance online publication, January 17, 2017; 10.1038/gt.2017.5 Abstract | Full Text Non-viral delivery of genome-editing nucleases for gene therapy M Wang, Z A Glass and Q Xu Gene Ther 2017 24: 144-150; advance online publication, October 31, 2016; 10.1038/gt.2016.72 Abstract | Full Text Genetic pharmacology: progresses in siRNA delivery and therapeutic applications D Scherman, A Rousseau, P Bigey and V Escriou Gene Ther 2017 24: 151-156; advance online publication, January 25, 2017; 10.1038/gt.2017.6 Abstract | Full Text Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy L Jiang, P Vader and R M Schiffelers Gene Ther 2017 24: 157-166; advance online publication, January 31, 2017; 10.1038/gt.2017.8 Abstract | Full Text Original Articles Top Adeno-associated virus-mediated expression of myostatin propeptide improves the growth of skeletal muscle and attenuates hyperglycemia in db/db mice J G Jiang, G F Shen, J Li, C Qiao, B Xiao, H Yan, D W Wang and X Xiao Gene Ther 2017 24: 167-175; advance online publication, December 16, 2016; 10.1038/gt.2016.85 Abstract | Full Text Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction I Alevizos, C Zheng, A P Cotrim, S Liu, L McCullagh, M E Billings, C M Goldsmith, M Tandon, E J Helmerhorst, M A Catalán, S J Danielides, P Perez, N P Nikolov, J A Chiorini, J E Melvin, F G Oppenheim, G G Illei and B J Baum Gene Ther 2017 24: 176-186; advance online publication, December 20, 2016; 10.1038/gt.2016.87 Abstract | Full Text Evidence for the in vivo safety of insulated foamy viral vectors D L Browning, E M Everson, D J Leap, J D Hocum, H Wang, G Stamatoyannopoulos and G D Trobridge Gene Ther 2017 24: 187-198; advance online publication, December 26, 2016; 10.1038/gt.2016.88 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.